Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022
Synopsis

Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018–2019

Ian Kracalik1Comments to Author , D. Cal Ham1, Gillian McAllister, Amanda R. Smith, Maureen Vowles, Kelly Kauber, Melba Zambrano, Gretchen Rodriguez, Kelley Garner, Kaitlyn Chorbi, P. Maureen Cassidy, Shannon McBee, Rhett J. Stoney, Kathleen Moser, Margarita E. Villarino, Oscar E. Zazueta, Amelia Bhatnagar, Erisa Sula, Richard A. Stanton, Allison C. Brown, Alison L. Halpin, Lauren Epstein, Maroya Spalding Walters, and for the Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-Resistant Pseudomonas aeruginosa Medical Tourism Investigation Team2
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (I. Kracalik, D. Cal Ham, G. McAllister, R.J. Stoney, K. Moser, M.E. Villarino, A. Bhatnagar, E. Sula, R.A. Stanton, A.C. Brown, A.L. Halpin, L. Epstein, M. Spalding Walters); Utah Department of Health, Salt Lake City, Utah, USA (A.R. Smith, M. Vowles); Washington State Department of Health, Olympia, Washington, USA (K. Kauber); Texas Department of State Health Services, Austin, Texas, USA (M. Zambrano, G. Rodriguez); Arkansas Department of Health, Little Rock, Arkansas, USA (K. Garner); Arizona Department of Health Services, Phoenix, Arizona, USA (K. Chorbi); Oregon Health Authority, Portland, Oregon, USA (P.M. Cassidy); West Virginia Department of Health and Human Resources, Charleston, West Virginia, USA (S. McBee); Secretaría de Salud de Baja California, Mexicali, Mexico (O.E. Zazueta)

Main Article

Table 2

Characteristics and interview responses from 160 US residents who underwent surgery at facility A in Tijuana, Mexico, August 1, 2018–March 1, 2019*

Characteristic Total, n = 160 Case status‡
Risk period†
Confirmed, probable, and suspected, n = 18 Confirmed and probable, n = 12 Noncases, n = 142
High risk, n = 92 Low risk, n = 68
Sex
M 28 (18) 20 (22) 8 (12) 2 (11) 0 26 (18)
F
132 (83)
72 (78)
60 (88)

16 (89)
12 (100)
116 (82)
Median age y (IQR) 43 (34–49) 43 (36–49) 43.5 (32–49) 45 (32.5–52.5) 41 (31–53) 43 (34.3–49)
Unknown or declined to answer
11 (7)
7 (8)
4 (6)

1 (6)
1 (8)
10 (7)
Procedure performed
Gastric sleeve 131 (82) 70 (76)§ 61 (90)§ 15 (83) 10 (83) 116 (82)
Laparoscopic gastric sleeve¶ 50 (31) 23 (25)§ 27 (40)§ 5(28) 4 (33) 45 (32)
Unspecified gastric sleeve# 79 (49) 47 (51) 32 (47) 10 (56) 6 (50) 69 (49)
Open gastric sleeve 2 (1) 0 2 (3) 0 0 2 (1)
Revision of previous surgery 8 (9) 2 (3) 3 (17) 3 (25)** 7 (5)
Gastric bypass 9 (6) 5 (5) 4 (6) 0 0 9 (6)
Other 9 (6) 4 (4) 5 (7) 0 0 9 (6)
Unknown or declined to answer
11 (7)
10 (11)§
1 (2)§

1 (6)
0
10 (7)
Surgeon who performed procedures
Surgeon 1 139 (87) 82 (89) 57 (84) 16 (89) 11 (92) 123 (87)
Surgeon 6†† 1 (<1) 1 (1) 0 0 0 1 (<1)
Unknown or declined to answer
20 (13)
9 (10)
11 (16)

2 (11)
1 (8)
18 (13)
Factors contributing to decision to have surgery abroad
Lower cost 132 (83) 75 (82) 57 (84) 14 (78) 9 (75) 118 (83)
Recommendations from friends or family 83 (52) 46 (50) 37 (54) 8 (44) 7 (58) 75 (53)
Did not meet weight qualifications for surgery in the United States 36 (23) 22 (24) 14 (21) 1 (6) 1 (8) 35 (25)
Convenience/shorter wait time 36 (23) 22 (24) 14 (21) 7 (39) 6 (50)** 29 (20)
Insurance would not approve/lack of insurance 9 (6) 3 (3) 6 (9) 1 (6) 1 (8) 8 (6)
Other
13 (8)
8 (9)
5 (7)

3 (17)
0
10 (7)
Unknown or declined to answer 7 (4) 5 (5) 2 (3) 0 0 7 (5)
Had concerns over quality of care before surgery (yes), n = 151
45 (30)
30 (36)
15 (22)

7 (41)
4 (36)
38 (28)
Of those with concerns, what were they?, n = 45
Surgery in a foreign country 13 (29) 8 (27) 5 (33) 3 (43) 2 (50) 10 (26)
Infection or other adverse outcome 8 (18) 7 (23) 1 (7) 3 (43) 2 (50) 5 (13)
General 11 (24) 6 (20) 5 (33) 0 0 11 (29)
Unknown or declined to answer 14 (31) 10 (33) 4 (27) 1 (14) 0 13 (34)
Aware of negative media stories or travel advisories about facility A before surgery (yes), n = 155‡‡ 41 (27) 24 (27) 17 (25) 7 (39) 6 (50) 34 (25)
Awareness from CDC Travel Health Notice before surgery, n = 41§§
5 (12)
5 (21)
0

3 (43)**
3 (50)**
2 (6)
Factors contributing to decision to have surgery, n = 41
Cost 22 (54) 12 (50) 10 (59) 4 (57) 3 (50) 18 (53)
Already paid 9 (22) 8 (33) 1 (6) 2 (29) 1 (17) 7 (21)
Unable to receive deposit refund 3 (7) 2 (8) 1 (6) 1 (14) 0 2 (6)
Already booked travel 6 (15) 6 (25) 0 2 (29) 1 (17) 4 (12)
Short wait time 2 (5) 2 (8) 0 1 (14) 0 1 (3)
Received assurances from travel agency/facility 16 (39) 12 (50) 4 (24) 5 (71) 4 (67) 11 (32)
Received assurances from previous patients 9 (22) 6 (25) 3 (18) 2 (29) 1 (17) 7 (21)
Other 8 (20) 2 (8)§ 6 (35)§ 2 (29) 1 (17) 6 (18)
Unknown or declined to answer 1 (2) 1 (4) 0 0 0 1 (3)

*Values are no.(%) unless indicated otherwise. CDC, Centers for Disease Control and Prevention; IQR, interquartile range. †Persons who had surgery on or after January 1, 2019, were classified as higher risk for new onset or ongoing postoperative infections. Persons who had surgery before January 1, 2019, were classified as lower risk because of the longer elapsed time since surgery. ‡A confirmed case was isolation of Verona integron‒encoded, metallo-β-lactamase‒producing, carbapenem-resistant Pseudomonas aeruginosa from a patient who had surgery during January 2018–December 2019, and within 45 d before specimen collection. A probable case was isolation of carbapenem-resistant P. aeruginosa, with isolate unavailable for carbapenemase testing, from a patient who had surgery during January 2018–December 2019, and within 45 d before specimen collection. A suspected case was infection (subjective or measured fever and >2 of the following at incision sites: pus, fluid draining, or warmth, redness and swelling) within 45 d of surgery in a patient who had surgery during January 2018–December 2019, and sought medical care but did not have a culture collected. §Statistically significant difference; p<0.05. ¶One patient underwent laparoscopic gastric sleeve and cholecystectomy. #Four patients underwent unspecified gastric sleeve and cholecystectomy. **Statistically significant difference compared with noncases; p<0.05. ††Persons who were interviewed reported surgery by surgeon 1 and another surgeon (surgeon 6) not reported by any case-patients. ‡‡Negative media stories about Facility A might have predated this outbreak §§Centers for Disease Control and Prevention issued an Alert Level 2 Travel Health Notice on January 9, 2019.

Main Article

1These authors contributed equally to this article.

2Members of this team are listed at the end of this article.

Page created: October 28, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external